AMEX · RVP

Retractable Technologies, Inc.

$0.68 $0.00 (+0.00%) 1D Market open

Key Metrics

$20.36M
Market cap
P/E · TTM
$37.15M
Revenue · TTM
−$6.29M
Net income
EPS · TTM $-0.21
Dividend yield
Free cash flow
Beta · 1Y 0.22
EBITDA · TTM $1.51M
Gross margin -2.1%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 5
    The stock moved +11.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 5
  • Feb 5
    The stock moved -8.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 5

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$20.36M
Enterprise value
Shares outstanding29.9M
52-wk range$0.60 – $1.14
Avg volume · 20D206.4K
Net cash
Book value / share$2.34
IndustrySurgical & Medical Instruments & Apparatus
ExchangeAMEX
About Retractable Technologies, Inc.
IPO dateMay 4, 2001
Employees201

Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.55
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross -2.1%
Operating -16.9%
Net -16.9%
FCF
ROE / ROIC -8.0% · -9.3%

Financial Health

Current ratio5.74
Quick ratio4.17
Debt / equity
Debt / EBITDA
Net cash
Working capital$49.51M

Cash Flow · TTM

Operating CF −$6.96M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

0.8
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings